Finally, Because Wei’s reported the uncertainty of the diagnosis of plasma Hsp90AA1 and the heterogeneity of the HSP90AA1 protein secreted by tumor cells, we randomly screened the plasma of 32 ELISA-negative breast cancer patients. This evidence concerns the gene HSP90AA1 and neoplasm.